Insuline Financial Statements From 2010 to 2024
| INSL Stock | ILS 210.00 8.00 3.96% |
Check Insuline Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insuline Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Insuline financial statements analysis is a perfect complement when working with Insuline Medical Valuation or Volatility modules.
Insuline |
Insuline Medical Company EBITDA Analysis
Insuline Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Insuline Medical EBITDA | (6.82 M) |
Most of Insuline Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insuline Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Insuline Medical reported earnings before interest,tax, depreciation and amortization of (6.82 Million). This is 100.78% lower than that of the Healthcare sector and 101.06% lower than that of the Medical Devices industry. The ebitda for all Israel stocks is 100.17% higher than that of the company.
Insuline Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Insuline Medical's current stock value. Our valuation model uses many indicators to compare Insuline Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Insuline Medical competition to find correlations between indicators driving Insuline Medical's intrinsic value. More Info.Insuline Medical is rated third overall in price to earning category among its peers. It also is rated third overall in revenue category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Insuline Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insuline Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Insuline Medical Financial Statements
Insuline Medical stakeholders use historical fundamental indicators, such as Insuline Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Insuline Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Insuline Medical's assets and liabilities are reflected in the revenues and expenses on Insuline Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Insuline Medical. Please read more on our technical analysis and fundamental analysis pages.
Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel. Insuline Medical is traded on Tel Aviv Stock Exchange in Israel.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Insuline Stock
Insuline Medical financial ratios help investors to determine whether Insuline Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Insuline with respect to the benefits of owning Insuline Medical security.